B. Pierre‐Louis

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study

Judy H. Cho, M. Regueiro, D. Schwartz, 2015, Alimentary pharmacology & therapeutics.